Keros Therapeutics, Inc. (KROS)

19.26 -0.27 (-1.38%) USD  |  NASDAQ  |  Jan 15, 16:00
19.27 +0.01 (+0.05%) Pre-Market: 20:00
More

Keros Therapeutics EBITDA (TTM)

EBITDA (TTM) Chart

View EBITDA (TTM) for KROS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Definition

View EBITDA Definition
Start Trial

EBITDA is an abbreviation for earnings before interest, taxes, depreciation, and amortization.

Read full definition.

EBITDA (TTM) Range, Past 5 Years

View EBITDA (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA (TTM) Benchmarks

View EBITDA (TTM) Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Pfizer Inc. Upgrade
Innoviva, Inc. Upgrade
Ocugen, Inc. Upgrade
Bionano Genomics, Inc. Upgrade